Representative Marjorie Taylor Greene (R-Georgia) has made headlines with her recent stock purchases, including shares of Novo Nordisk A/S (NYSE:NVO). According to a filing on October 20, 2025, Greene acquired between $1,001 and $15,000 in Novo Nordisk stock on October 15, 2025. This move is part of a broader investment strategy, as she also purchased shares in several other prominent companies on the same day.
In addition to Novo Nordisk, Greene’s recent acquisitions include shares of Amazon.com (NASDAQ:AMZN), Adobe (NASDAQ:ADBE), Exelon (NASDAQ:EXC), the iShares Bitcoin Trust ETF (NASDAQ:IBIT), and Tesla (NASDAQ:TSLA). All these transactions took place on October 15, 2025, with each investment falling within the same financial range.
Stock Performance and Analyst Ratings
As of October 20, 2025, shares of Novo Nordisk opened at $53.37. The stock has experienced significant volatility over the past year, with a 52-week low of $45.05 and a high of $116.43. The company boasts a market capitalization of $238.29 billion and has reported a price-to-earnings ratio of 14.66.
Recent earnings data indicates a strong performance for Novo Nordisk. The company reported an earnings per share (EPS) of $0.97 for the last quarter, surpassing analysts’ expectations of $0.93. Revenue for the quarter reached $11.69 billion, reflecting robust demand for its pharmaceutical products.
Analysts have shown varied opinions on Novo Nordisk’s stock. In a report dated September 9, Sanford C. Bernstein upgraded the stock from a “market perform” rating to “outperform.” Conversely, Morgan Stanley downgraded the stock from “overweight” to “underweight,” adjusting its price target from $59.00 to $47.00. The consensus rating among analysts stands at “Moderate Buy,” with an average price target of $76.00.
Institutional Investors and Dividends
Institutional investors have been active in adjusting their stakes in Novo Nordisk. Jennison Associates LLC increased its holdings by 0.3% during the second quarter, now owning approximately 18.89 million shares valued at around $1.30 billion. Other notable investors include Loomis Sayles & Co. L P, which raised its stake by 1.5%, and Kingstone Capital Partners Texas LLC, which dramatically increased its holdings by over 301,000%.
On August 26, 2025, Novo Nordisk declared a semi-annual dividend of $0.4119 per share, which was paid out to investors on record as of August 18, 2025. This dividend represents a yield of 240.0%, with a payout ratio of 22.53%.
Marjorie Taylor Greene, who has represented Georgia’s 14th Congressional District since January 3, 2021, is currently running for re-election in the upcoming 2026 election. Her recent investment activities have drawn attention as she continues to engage both in legislative duties and personal financial ventures.
Novo Nordisk A/S, known for its focus on diabetes and obesity care, operates globally, providing essential pharmaceutical products across various markets, including Europe, North America, and Asia. With its strong financials and positive market outlook, it remains an appealing option for investors like Greene.
